Cytotoxic Effects of Verbascoside on MCF-7 and MDA-MB-231 2021

Hülya Şenol, and Pınar Tulay, and Mahmut Çerkez Ergören, and Azmi Hanoğlu, and İhsan Çalış, and Gamze Mocan
Near East University Faculty of Medicine, Department of Medical Biology, Nicosia, North Cyprus

Verbascoside, also known as acteoside/kusaginin, has attracted a great attention due to its pharmacological features. In this study, we aimed to determine the cytotoxic effects of pure verbascoside isolated from Phlomis nissolii L. plant in both MCF-7 and MDA-MB-231 cell lines in vitro. MCF-7 and MDA-MB 231 cells were treated with verbascoside (100, 48, 25, 10, 1, 0.5, and 0.1 μM) for 24, 48, and 72 hours. Cytotoxic effect of verbascoside in MCF-7 and MDA-MB-231 cells was assessed using TEBU-BIO cell counting kit 8. IC50 values for 24, 48, and 72 h verbascoside exposure of MCF-7 cells were determined as 0.127, 0.2174, and 0.2828 μM, respectively. R2 values were calculated as 0.9630, 0.8789 and 0.8752, respectively. Two-Way ANOVA multiple comparison test results showed that 100 μM verbascoside has the highest cytotoxic effect on MCF-7 breast cancer (BC) cells after 72 h of exposure. IC50 values for 24, 48 and 72 h verbascoside exposure of MDA-MB 231 cells were determined as 0.1597, 0.2584 and 0.2563 μM, respectively and R2 values were calculated as 0.8438, 0.5107 and 0.9203, respectively. Two-Way ANOVA multiple comparisons test results showed that 100 μM verbascoside has the highest cytotoxic effect on MDA-MB 231 BC cells after 24, 48 and 72 h of exposure.

UI MeSH Term Description Entries

Related Publications

Hülya Şenol, and Pınar Tulay, and Mahmut Çerkez Ergören, and Azmi Hanoğlu, and İhsan Çalış, and Gamze Mocan
March 2018, Chemistry Central journal,
Hülya Şenol, and Pınar Tulay, and Mahmut Çerkez Ergören, and Azmi Hanoğlu, and İhsan Çalış, and Gamze Mocan
September 2017, Bioorganic & medicinal chemistry letters,
Hülya Şenol, and Pınar Tulay, and Mahmut Çerkez Ergören, and Azmi Hanoğlu, and İhsan Çalış, and Gamze Mocan
June 2017, Human & experimental toxicology,
Hülya Şenol, and Pınar Tulay, and Mahmut Çerkez Ergören, and Azmi Hanoğlu, and İhsan Çalış, and Gamze Mocan
January 2023, Advanced biomedical research,
Hülya Şenol, and Pınar Tulay, and Mahmut Çerkez Ergören, and Azmi Hanoğlu, and İhsan Çalış, and Gamze Mocan
November 2007, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition,
Hülya Şenol, and Pınar Tulay, and Mahmut Çerkez Ergören, and Azmi Hanoğlu, and İhsan Çalış, and Gamze Mocan
January 2015, PloS one,
Hülya Şenol, and Pınar Tulay, and Mahmut Çerkez Ergören, and Azmi Hanoğlu, and İhsan Çalış, and Gamze Mocan
March 2018, Molecules (Basel, Switzerland),
Hülya Şenol, and Pınar Tulay, and Mahmut Çerkez Ergören, and Azmi Hanoğlu, and İhsan Çalış, and Gamze Mocan
October 2011, Anticancer research,
Hülya Şenol, and Pınar Tulay, and Mahmut Çerkez Ergören, and Azmi Hanoğlu, and İhsan Çalış, and Gamze Mocan
February 2004, Canadian journal of physiology and pharmacology,
Hülya Şenol, and Pınar Tulay, and Mahmut Çerkez Ergören, and Azmi Hanoğlu, and İhsan Çalış, and Gamze Mocan
March 2020, Xenobiotica; the fate of foreign compounds in biological systems,
Copied contents to your clipboard!